Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Graft Versus Host Disease
Related studies linked through entity extraction aliases.
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Campath-1H + FK506 and Methylprednisolone for GVHD
- Status
- COMPLETED
- Phase
- PHASE2
Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- NA
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE2
Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract
- Status
- COMPLETED
- Phase
- NA
Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE3
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia
- Status
- COMPLETED
- Phase
- NA
Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE3
Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE3
Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia
- Status
- UNKNOWN
- Phase
- NA
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2